Effect of prednisolone on linear growth in children with nephrotic syndrome

Abstract Objective This study aims at determining the relationship between prednisolone cumulative dose and linear growth in pre-pubertal children with idiopathic nephrotic syndrome. Method This cross-sectional study was conducted on all children with idiopathic nephrotic syndrome registered to the pediatric nephrology department at the main referral children's hospital in Southwestern Iran. Inclusion criteria included age (males <12 years; females <10 years), >6 months of use, and the minimum prednisolone cumulative dose of 152 mg/kg. The exclusion criteria were individuals who had entered puberty or had other diseases affecting linear growth. Based on the prednisolone cumulative dose of ≥550 mg/kg (four or more relapses), the children were divided into two groups. All data regarding age, height, and weight at disease onset and the last visit, bone age, and the parents’ height were collected. Secondary variables including mid-parental target height and predicted adult height were also calculated. Height data were compared between the different rates of relapse. Results A total of 97 children (68% male) were enrolled. Their post-treatment mean height Z-score was less than that obtained before treatment (−0.584 vs. −0.158; p = 0.001). Subjects with higher prednisolone cumulative doses were found to have more reduction in height Z-score (p = 0.001). Post-treatment height prediction also showed less growth potential compared to pre-treatment target height (p = 0.006). Thirty-three children (34.4%) had four or more relapses, among whom more mean-height Z-score decreases were found compared to those with less-frequent relapses (−0.84 vs. −0.28; p = 0.04). Conclusion This study showed the negative effect of cumulative dosages of prednisolone on linear growth, which was greater in children with four or more relapses.

Saved in:
Bibliographic Details
Main Authors: Valavi,Ehsan, Aminzadeh,Majid, Amouri,Parisa, Rezazadeh,Afshin, Beladi-Mousavi,Maedeh
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Pediatria 2020
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0021-75572020000100117
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0021-75572020000100117
record_format ojs
spelling oai:scielo:S0021-755720200001001172020-02-28Effect of prednisolone on linear growth in children with nephrotic syndromeValavi,EhsanAminzadeh,MajidAmouri,ParisaRezazadeh,AfshinBeladi-Mousavi,Maedeh Prednisolone Linear growth Children Nephrotic syndrome Abstract Objective This study aims at determining the relationship between prednisolone cumulative dose and linear growth in pre-pubertal children with idiopathic nephrotic syndrome. Method This cross-sectional study was conducted on all children with idiopathic nephrotic syndrome registered to the pediatric nephrology department at the main referral children's hospital in Southwestern Iran. Inclusion criteria included age (males <12 years; females <10 years), >6 months of use, and the minimum prednisolone cumulative dose of 152 mg/kg. The exclusion criteria were individuals who had entered puberty or had other diseases affecting linear growth. Based on the prednisolone cumulative dose of ≥550 mg/kg (four or more relapses), the children were divided into two groups. All data regarding age, height, and weight at disease onset and the last visit, bone age, and the parents’ height were collected. Secondary variables including mid-parental target height and predicted adult height were also calculated. Height data were compared between the different rates of relapse. Results A total of 97 children (68% male) were enrolled. Their post-treatment mean height Z-score was less than that obtained before treatment (−0.584 vs. −0.158; p = 0.001). Subjects with higher prednisolone cumulative doses were found to have more reduction in height Z-score (p = 0.001). Post-treatment height prediction also showed less growth potential compared to pre-treatment target height (p = 0.006). Thirty-three children (34.4%) had four or more relapses, among whom more mean-height Z-score decreases were found compared to those with less-frequent relapses (−0.84 vs. −0.28; p = 0.04). Conclusion This study showed the negative effect of cumulative dosages of prednisolone on linear growth, which was greater in children with four or more relapses.info:eu-repo/semantics/openAccessSociedade Brasileira de PediatriaJornal de Pediatria v.96 n.1 20202020-02-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0021-75572020000100117en10.1016/j.jped.2018.07.014
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Valavi,Ehsan
Aminzadeh,Majid
Amouri,Parisa
Rezazadeh,Afshin
Beladi-Mousavi,Maedeh
spellingShingle Valavi,Ehsan
Aminzadeh,Majid
Amouri,Parisa
Rezazadeh,Afshin
Beladi-Mousavi,Maedeh
Effect of prednisolone on linear growth in children with nephrotic syndrome
author_facet Valavi,Ehsan
Aminzadeh,Majid
Amouri,Parisa
Rezazadeh,Afshin
Beladi-Mousavi,Maedeh
author_sort Valavi,Ehsan
title Effect of prednisolone on linear growth in children with nephrotic syndrome
title_short Effect of prednisolone on linear growth in children with nephrotic syndrome
title_full Effect of prednisolone on linear growth in children with nephrotic syndrome
title_fullStr Effect of prednisolone on linear growth in children with nephrotic syndrome
title_full_unstemmed Effect of prednisolone on linear growth in children with nephrotic syndrome
title_sort effect of prednisolone on linear growth in children with nephrotic syndrome
description Abstract Objective This study aims at determining the relationship between prednisolone cumulative dose and linear growth in pre-pubertal children with idiopathic nephrotic syndrome. Method This cross-sectional study was conducted on all children with idiopathic nephrotic syndrome registered to the pediatric nephrology department at the main referral children's hospital in Southwestern Iran. Inclusion criteria included age (males <12 years; females <10 years), >6 months of use, and the minimum prednisolone cumulative dose of 152 mg/kg. The exclusion criteria were individuals who had entered puberty or had other diseases affecting linear growth. Based on the prednisolone cumulative dose of ≥550 mg/kg (four or more relapses), the children were divided into two groups. All data regarding age, height, and weight at disease onset and the last visit, bone age, and the parents’ height were collected. Secondary variables including mid-parental target height and predicted adult height were also calculated. Height data were compared between the different rates of relapse. Results A total of 97 children (68% male) were enrolled. Their post-treatment mean height Z-score was less than that obtained before treatment (−0.584 vs. −0.158; p = 0.001). Subjects with higher prednisolone cumulative doses were found to have more reduction in height Z-score (p = 0.001). Post-treatment height prediction also showed less growth potential compared to pre-treatment target height (p = 0.006). Thirty-three children (34.4%) had four or more relapses, among whom more mean-height Z-score decreases were found compared to those with less-frequent relapses (−0.84 vs. −0.28; p = 0.04). Conclusion This study showed the negative effect of cumulative dosages of prednisolone on linear growth, which was greater in children with four or more relapses.
publisher Sociedade Brasileira de Pediatria
publishDate 2020
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0021-75572020000100117
work_keys_str_mv AT valaviehsan effectofprednisoloneonlineargrowthinchildrenwithnephroticsyndrome
AT aminzadehmajid effectofprednisoloneonlineargrowthinchildrenwithnephroticsyndrome
AT amouriparisa effectofprednisoloneonlineargrowthinchildrenwithnephroticsyndrome
AT rezazadehafshin effectofprednisoloneonlineargrowthinchildrenwithnephroticsyndrome
AT beladimousavimaedeh effectofprednisoloneonlineargrowthinchildrenwithnephroticsyndrome
_version_ 1756375976720203776